Vivian Pratt is a counsel in the firm's FDA Group and a member of its Life Sciences Practice. Ms. Pratt joined Goodwin Procter in 2009.

Ms. Pratt advises businesses on all aspects of product approval and compliance, including advice on the Quality Systems Regulation (QSR) and responses to FDA inspections and warning letters. She has conducted due diligence investigations of drug, biologic and medical device firms for initial and secondary public offerings before the U.S. Securities and Exchange Commission. In addition, Ms. Pratt assists clients with strategies pertaining to product submissions to FDA, advertising and promotional materials, conduct of clinical trials and post-approval reporting requirements.